- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04519021
Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in Nepal
Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in Nepal: A Report From Web-Based Survey
Study Overview
Status
Conditions
Detailed Description
Objective To understand the knowledge, attitude and treatment practices of gout among doctors who regularly interacted with gout patients.
Methodology Study population: Physicians (including practicing medical graduates, post-graduates in internal medicine, family medicine) and orthopedic surgeons were selected randomly from the list of data from the Nepal Medical Council registry. All internists with valid email ID on the registry of the "society of internal medicine of Nepal" (SIMON) were included. Also, a list of MBBS graduates, family medicine and orthopedic practitioners working in the peripheral set-up of Nepal was obtained and a random selection with computer-generated random number table based on council registration number was made for enrollment into the survey. Estimating a response rate of 30%, a total of 1200 clinicians were selected based on their council registration number for the invitation to participate in the survey.
Survey instrument: A standardized questionnaire was designed by a 3-member committee of NRA focusing on the areas of knowledge, attitude and practice of gout with 9 questions pertaining to demographic parameters, 8 to knowledge about the disease, 11 to attitude and 10 to practice behaviors [tables 1-4]. The questions were designed as multiple-choice questions (MCQ) to be marked by the respondent. Few questions had the provision of selecting more than 1 options. Open- ended questions were avoided to save the time of the respondents and thus reduce the attrition rates[10].
Procedure: An email containing a letter of invitation for participation was sent to each of the selected participant. It mentioned why they were receiving the email, the objectives of the survey, the assurance of anonymity and confidentiality and a total answering time of less than 5 minutes for encouraging participation. A link to the Google-form was attached in the mail itself and a mention was made on the implied consent for participation in clicking the link. A reminder email was sent after 1 week to all irrespective of whether they had responded earlier.
Platform: A web-based platform was chosen with the use of Google-forms which was compatible and user friendly to both browser and mobile users and to both iOS and Android users. Multiple entries from the same email link were blocked. Web-based platform was chosen over email survey because it provides the ability to transfer survey responses directly into a database, eliminating transcription errors and preventing survey alteration by the survey respondent and most importantly maintaining confidentiality and anonymity of respondents[11]. The answers were collected anonymously in an excel sheet at the main server for analysis.
Statistical analysis: Simple descriptive statistics were used to describe the frequency or correct responses. Chi-square test was performed to assess the difference in knowledge, attitude, and practices between clinicians with different medical qualifications. Analysis was done using SPSS version 21 (SPSS, Inc., Chicago, IL, USA).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Kathmandu, Nepal
- National center for Rheumatic Diseases
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Physicians (including practicing medical graduates, post-graduates in internal medicine, family medicine)
- orthopedic surgeons
- with valid email ID on the registry of the "society of internal medicine of Nepal" (SIMON)
Exclusion Criteria:
- who did not give consent
- clinicians other than above mentioned faculty
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluation of knowledge
Time Frame: 3 months
|
evaluation of knowledge on gout among clinicians
|
3 months
|
evaluation of attitude
Time Frame: 3 months
|
evaluation of attitude on gout among clinicians
|
3 months
|
evaluation of practice
Time Frame: 3 months
|
evaluation of practice on gout among clinicians
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07/2076
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gout
-
Ai PengRecruitingGout Flare | Intercritical Gout | Advanced Gout | Asymptomatic HyperuricemiaChina
-
AmgenCompletedUncontrolled Gout | Chronic GoutUnited States
-
Sheffield Hallam UniversityCherry Research CommitteeUnknown
-
Olatec Therapeutics LLCRecruitingArthritis | Joint Pain | Gout | Gout Flare | Gouty Arthritis | Acute Gout Flare | Gout AttackUnited States, Spain, France
-
GeneScience Pharmaceuticals Co., Ltd.Huashan HospitalNot yet recruitingAcute Gout | Gout Initiating Urico-lowering TherapyChina
-
GeneScience Pharmaceuticals Co., Ltd.Huashan HospitalRecruitingGout Flare | Acute GoutChina
-
AmgenCompletedGout | Chronic Uncontrolled Gout | Uncontrolled GoutUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout and Hyperuricemia
-
Guangdong Provincial Hospital of Traditional Chinese...RecruitingAcute Pain | Acupuncture | Acute Gout ArthritisChina